Aignostics
Berlin
About Aignostics
Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of precise heatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $54.8M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2024)
- Website: aignostics.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics, Machine Learning, Software
Social Profiles
Canonical: https://fsome.com/organization/aignostics-71538 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.